Inhibitors of the renin-angiotensin system ameliorates clinical and pathological aspects of experimentally induced nephrotoxic serum nephritis

References

• Lee SB, Kalluri R. Mechanistic connection between inflammation and fibrosis. Kidney Int Suppl. 2010;78:S22–S26.
   Web of Science ®Google Scholar
• Ougaard M, Kvist K, Jensen H, et al. Murine nephrotoxic nephritis as a model of chronic kidney disease. Int J Nephrol. 2018;2018:1. Manuscript 8424502 accepted for publication.
   Google Scholar
• Eddy AA, Lopez-Guisa JM, Okamura DM, et al. Investigating mechanisms of chronic kidney disease in mouse models. Pediatr Nephrol. 2012;27:1233–1247.
   PubMed Web of Science ®Google Scholar
• Nagai H, Yamada H, Nishigaki T, et al. The susceptibility of experimental glomerulonephritis in six different strains of mice. J Pharmacobio-Dyn. 1985;8:586–589.
   PubMedGoogle Scholar
• Fyhrquist F, Metsarinne K, Tikkanen I. Role of angiotensin II in blood pressure regulation and in the pathophysiology of cardiovascular disorders. J Hum Hypertens. 1995;9 (Suppl 5):S19–S24.
   PubMed Web of Science ®Google Scholar
• Ruiz-Ortega M, Ruperez M, Esteban V, et al. Angiotensin II: a key factor in the inflammatory and fibrotic response in kidney diseases. Nephrol Dial Transplant. 2006;21:16–20.
   PubMed Web of Science ®Google Scholar
• K/DOQI. Clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39:S1–S266.
   PubMed Web of Science ®Google Scholar
• Lautrette A, Li S, Alili R, et al. Angiotensin II and EGF receptor cross-talk in chronic kidney diseases: a new therapeutic approach. Nat Med. 2005;11:867.
   PubMed Web of Science ®Google Scholar
• Husain K, Suarez E, Isidro A, et al. Effect of paricalcitol and enalapril on renal inflammation/oxidative stress in atherosclerosis. Wjbc. 2015;6:240–248.
   Google Scholar
• Ilhan H, Wang H, Gildehaus FJ, et al. Nephroprotective effects of enalapril after [177Lu]-DOTATATE therapy using serial renal scintigraphies in a murine model of radiation-induced nephropathy. EJNMMI Res. 2016;6:64.
   PubMed Web of Science ®Google Scholar
• Ellery SJ, Cai X, Walker DD, et al. Transcutaneous measurement of glomerular filtration rate in small rodents: through the skin for the win? Nephrol (Carlton, Vic). 2015;20:117–123.
   PubMed Web of Science ®Google Scholar
• Soendergaard C, Nielsen OH, Skak K, et al. Objective quantification of immune cell infiltrates and epidermal proliferation in psoriatic skin: a comparison of digital image analysis and manual counting. Appl Immunohistochem Mol Morphol. 2016;24:453–458.
   PubMedGoogle Scholar
• Guo JK, Marlier A, Shi H, et al. Increased tubular proliferation as an adaptive response to glomerular albuminuria. J Am Soc Nephrol. 2012;23:429–437.
   PubMed Web of Science ®Google Scholar
• Wharram BL, Goyal M, Wiggins JE, et al. Podocyte depletion causes glomerulosclerosis: diphtheria toxin–induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene. J Am Soc Nephrol. 2005;16:2941–2952.
   PubMed Web of Science ®Google Scholar
• Steffes MW, Osterby R, Chavers B, et al. Mesangial expansion as a central mechanism for loss of kidney function in diabetic patients. Diabetes. 1989;38:1077–1081.
   PubMed Web of Science ®Google Scholar
• Schnaper HW. Remnant nephron physiology and the progression of chronic kidney disease. Pediatr Nephrol. 2014;29:193–202.
   PubMed Web of Science ®Google Scholar
• Fogo AB, Lusco MA, Najafian B, et al. AJKD atlas of renal pathology: membranoproliferative glomerulonephritis. Am J Kidney Dis. 2015;66:e19–e20.
   PubMed Web of Science ®Google Scholar
• Fogo AB, Lusco MA, Najafian B, et al. AJKD atlas of renal pathology: anti-glomerular basement membrane antibody-mediated glomerulonephritis. Am J Kidney Dis. 2016;68:e29–e30.
   PubMed Web of Science ®Google Scholar
• Jennette JC, Thomas DB. Crescentic glomerulonephritis. Nephrol Dial Transplant. 2001;16 (Suppl 6):80–82.
   PubMed Web of Science ®Google Scholar
• Agarwal D, Elks CM, Reed SD, et al. Chronic exercise preserves renal structure and hemodynamics in spontaneously hypertensive rats. Antioxid Redox Signal. 2012;16:139–152.
   PubMed Web of Science ®Google Scholar
• Haensly WE. Metaplasia of the parietal layer of Bowman's capsule in the human kidney: incidence in alcoholic liver disease and hypertension. Histol Histopathol. 1988;3:235–240.
   PubMed Web of Science ®Google Scholar
• Hamazaki S, Okada S, Ebina Y, et al. Nephrotoxicity of ferric nitrilotriacetate. An electron-microscopic and metabolic study. Am J Pathol. 1986;123:343–350.
   PubMed Web of Science ®Google Scholar
• Alfrey AC, Froment DH, Hammond WS. Role of iron in the tubulo-interstitial injury in nephrotoxic serum nephritis. Kidney Int. 1989;36:753–759.
   PubMed Web of Science ®Google Scholar
• Kaissling B, LeHir M, Kriz W. Renal epithelial injury and fibrosis. Biochim Biophys Acta. 2013;1832:931–939.
   PubMed Web of Science ®Google Scholar
• Mezzano SA, Ruiz-Ortega M, Egido J. Angiotensin II and renal fibrosis. Hypertension. 2001;38:635.
   PubMed Web of Science ®Google Scholar
• van der Meer IM, Cravedi P, Remuzzi G. The role of renin angiotensin system inhibition in kidney repair. Fibrogenesis Tissue Repair. 2010;3:7.
   PubMedGoogle Scholar
• Rüster C, Wolf G. Renin-angiotensin-aldosterone system and progression of renal disease. J Am Soc Nephrol. 2006;17:2985–2991.
   PubMed Web of Science ®Google Scholar
• Jackson B, Debrevi L. Effect of enalapril treatment on progression of the nephrotoxic serum nephritis model of renal failure in the rat. Clin Exp Pharmacol Physiol. 1988;15:131–136.
   PubMed Web of Science ®Google Scholar
• Mendoza-Torres E, Oyarzun A, Mondaca-Ruff D, et al. ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension. Ther Adv Cardiovasc Dis. 2015;9:217–237.
   PubMedGoogle Scholar
• Silveira KD, Barroso LC, Vieira AT, et al. Beneficial effects of the activation of the angiotensin-(1–7) mas receptor in a murine model of adriamycin-induced nephropathy. PLoS One. 2013;8:e66082.
   PubMed Web of Science ®Google Scholar
• Simoes ESAC, Teixeira MM. ACE inhibition, ACE2 and angiotensin-(1-7) axis in kidney and cardiac inflammation and fibrosis. Pharmacol Res. 2016;107:154–162.
   PubMed Web of Science ®Google Scholar